tiprankstipranks
Sumitomo Dainippon Pharma Co Ltd (JP:4506)
:4506
Japanese Market
4506
Sumitomo Dainippon Pharma Co
RESEARCH TOOLSreports

Sumitomo Dainippon Pharma Co (4506) Income Statement

7 Followers

Sumitomo Dainippon Pharma Co Income Statement

Last quarter (Q4 2025), Sumitomo Dainippon Pharma Co's total revenue was ¥105.65B, a decrease of -11.31% from the same quarter last year. In Q4, Sumitomo Dainippon Pharma Co's net income was ¥2.42B. See Sumitomo Dainippon Pharma Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 398.83B¥ 314.56B¥ 555.54B¥ 560.03B¥ 515.95B
Gross Profit
¥ 225.38B¥ 157.08B¥ 342.95B¥ 371.18B¥ 361.60B
Operating Expenses
¥ 202.96B¥ 158.55B¥ 331.74B¥ 314.62B¥ 293.22B
Depreciation and Amortization
¥ 25.56B¥ 37.77B¥ 41.26B¥ 38.35B¥ 22.67B
EBITDA
¥ 47.98B¥ 36.29B¥ 52.47B¥ 94.90B¥ 91.05B
Operating Income
¥ 22.42B¥ -1.48B¥ 11.20B¥ 56.55B¥ 68.38B
Other Income/Expenses
¥ -4.81B¥ -321.64B¥ -59.12B¥ 26.41B¥ 9.47B
Pretax Income
¥ 17.61B¥ -323.11B¥ -47.92B¥ 82.96B¥ 77.85B
Net Income
¥ 23.63B¥ -314.97B¥ -74.51B¥ 56.41B¥ 56.22B
Per Share Metrics
Basic EPS
¥ 59.49¥ -792.79¥ -187.55¥ 141.99¥ 141.50
Diluted EPS
¥ 59.49¥ -792.79¥ -187.55¥ 141.99¥ 141.50
Weighted Average Shares Outstanding
 397.29M 397.29M 397.29M 397.29M 397.29M
Weighted Average Shares Outstanding (Diluted)
 397.29M 397.29M 397.29M 397.29M 397.29M
Currency in JPY

Sumitomo Dainippon Pharma Co Earnings and Revenue History